Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jennifer Laudadio

Concepts (144)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
4
2015
165
1.140
Why?
Papillomaviridae
3
2015
101
0.880
Why?
Keratosis, Seborrheic
2
2015
3
0.570
Why?
Vulvar Diseases
2
2015
7
0.560
Why?
Alphapapillomavirus
2
2014
13
0.530
Why?
Pathology
1
2015
38
0.460
Why?
Fusion Proteins, bcr-abl
3
2009
17
0.450
Why?
Genomics
1
2015
238
0.430
Why?
Curriculum
2
2022
393
0.430
Why?
Neoplasm Invasiveness
2
2012
269
0.420
Why?
Uterine Cervical Dysplasia
1
2013
48
0.400
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
2009
45
0.380
Why?
Perineum
1
2012
24
0.380
Why?
Myxoma
1
2012
16
0.380
Why?
Mutagenesis, Insertional
2
2008
21
0.370
Why?
Vulvar Neoplasms
1
2012
58
0.360
Why?
Uterine Cervical Neoplasms
1
2013
275
0.340
Why?
Mass Screening
1
2013
343
0.340
Why?
In Situ Hybridization, Fluorescence
2
2007
231
0.300
Why?
Introns
1
2008
49
0.290
Why?
Carcinoma, Squamous Cell
1
2010
326
0.280
Why?
Protein Kinase Inhibitors
2
2013
204
0.280
Why?
Head and Neck Neoplasms
1
2010
288
0.280
Why?
Genes, erbB-2
1
2007
8
0.270
Why?
Actinomyces
1
2006
10
0.260
Why?
Actinomycosis
1
2006
10
0.260
Why?
Vaginal Smears
1
2006
28
0.260
Why?
Carcinoma, Transitional Cell
1
2005
51
0.240
Why?
Microsatellite Instability
1
2024
19
0.230
Why?
DNA Mismatch Repair
1
2024
16
0.230
Why?
Urinary Bladder Neoplasms
1
2005
158
0.220
Why?
Endometrial Neoplasms
1
2024
137
0.200
Why?
Humans
20
2024
50419
0.190
Why?
DNA, Viral
2
2014
134
0.190
Why?
Polymerase Chain Reaction
2
2014
447
0.180
Why?
Colorectal Neoplasms
1
2024
256
0.180
Why?
Fellowships and Scholarships
1
2022
120
0.180
Why?
Female
13
2024
27053
0.170
Why?
Middle Aged
7
2014
12579
0.150
Why?
Breast Neoplasms
1
2007
1198
0.140
Why?
Gastrointestinal Neoplasms
1
2015
40
0.120
Why?
Prognosis
4
2015
1974
0.120
Why?
Mucositis
1
2014
7
0.110
Why?
Oropharyngeal Neoplasms
1
2014
19
0.110
Why?
Histocytochemistry
1
2014
47
0.110
Why?
Microscopy
1
2014
58
0.110
Why?
Protein Structure, Tertiary
3
2009
241
0.110
Why?
Quinazolines
1
2013
33
0.110
Why?
Human Papillomavirus DNA Tests
1
2013
1
0.110
Why?
Virology
1
2013
6
0.110
Why?
Molecular Diagnostic Techniques
1
2013
32
0.100
Why?
Bile Duct Diseases
1
2013
11
0.100
Why?
United States Food and Drug Administration
1
2013
91
0.100
Why?
Genotype
1
2014
525
0.100
Why?
RNA, Messenger
2
2013
1085
0.100
Why?
Clinical Competence
1
2015
403
0.100
Why?
Phosphotransferases
2
2009
16
0.100
Why?
Aged
5
2014
9738
0.100
Why?
Carcinoma, Non-Small-Cell Lung
1
2013
153
0.090
Why?
Piperazines
2
2009
120
0.090
Why?
Cholelithiasis
1
2011
12
0.090
Why?
Cholecystectomy, Laparoscopic
1
2011
20
0.090
Why?
Pyrimidines
2
2009
187
0.090
Why?
In Situ Hybridization
1
2010
66
0.090
Why?
Smoking
1
2014
506
0.090
Why?
Endosonography
1
2011
94
0.090
Why?
Algorithms
1
2013
624
0.080
Why?
HIV Infections
1
2013
347
0.080
Why?
Diagnosis, Differential
1
2012
1029
0.070
Why?
Exons
1
2008
94
0.070
Why?
United States
2
2022
5005
0.070
Why?
Lung Neoplasms
1
2013
597
0.070
Why?
Adult
6
2022
13561
0.070
Why?
DNA Mutational Analysis
1
2008
175
0.070
Why?
Aged, 80 and over
3
2014
3233
0.070
Why?
Proto-Oncogenes
1
2007
27
0.070
Why?
Base Sequence
1
2008
622
0.070
Why?
Gene Amplification
1
2007
56
0.070
Why?
Amino Acid Sequence
1
2008
575
0.070
Why?
Receptor, erbB-2
1
2007
73
0.070
Why?
Molecular Sequence Data
1
2008
760
0.070
Why?
Male
7
2014
25866
0.060
Why?
Cell Division
1
2007
292
0.060
Why?
Young Adult
2
2013
4075
0.060
Why?
Intestinal Neoplasms
1
2024
8
0.060
Why?
Pathology, Clinical
1
2024
24
0.060
Why?
Immunohistochemistry
1
2007
955
0.050
Why?
Mutation
1
2009
1275
0.050
Why?
Intestine, Small
1
2024
110
0.050
Why?
Antineoplastic Agents
4
2014
1165
0.050
Why?
Sensitivity and Specificity
1
2005
855
0.050
Why?
Retrospective Studies
4
2022
6274
0.050
Why?
Adolescent
3
2011
6453
0.050
Why?
Disease-Free Survival
2
2014
439
0.050
Why?
Esophageal Neoplasms
1
2024
105
0.050
Why?
Pathology, Molecular
1
2022
22
0.050
Why?
Accreditation
1
2022
61
0.050
Why?
Neoplasm Recurrence, Local
1
2005
622
0.050
Why?
Combined Modality Therapy
2
2014
640
0.040
Why?
Reproducibility of Results
1
2024
1181
0.040
Why?
Education, Medical, Graduate
1
2022
214
0.040
Why?
Treatment Outcome
3
2014
5265
0.040
Why?
Benzamides
2
2009
50
0.040
Why?
Molecular Imaging
1
2015
54
0.030
Why?
Cyclin D3
1
2013
5
0.030
Why?
Survival
1
2013
11
0.030
Why?
Taxoids
1
2013
37
0.030
Why?
Cyclin D1
1
2013
52
0.030
Why?
Granulocyte Colony-Stimulating Factor
1
2013
63
0.030
Why?
Radiotherapy
1
2014
125
0.030
Why?
Polyethylene Glycols
1
2013
84
0.030
Why?
Anti-Retroviral Agents
1
2013
14
0.030
Why?
Liver Cirrhosis, Biliary
1
2013
11
0.030
Why?
Jaundice
1
2013
19
0.030
Why?
Patient Compliance
1
2014
232
0.030
Why?
Drug Administration Schedule
1
2013
373
0.030
Why?
Cholestasis
1
2013
40
0.020
Why?
Recombinant Proteins
1
2013
477
0.020
Why?
Syndrome
1
2013
236
0.020
Why?
Cisplatin
1
2013
283
0.020
Why?
CD4-Positive T-Lymphocytes
1
2013
158
0.020
Why?
Technetium Tc 99m Lidofenin
1
2011
1
0.020
Why?
Ursodeoxycholic Acid
1
2011
5
0.020
Why?
Cholagogues and Choleretics
1
2011
6
0.020
Why?
Cholangiography
1
2011
10
0.020
Why?
Cholangiopancreatography, Magnetic Resonance
1
2011
9
0.020
Why?
False Negative Reactions
1
2011
29
0.020
Why?
Ceftriaxone
1
2011
26
0.020
Why?
Age of Onset
1
2011
109
0.020
Why?
Biopsy
1
2013
588
0.020
Why?
Antibiotic Prophylaxis
1
2011
64
0.020
Why?
Radiography, Interventional
1
2011
57
0.020
Why?
Pancreatitis
1
2011
59
0.020
Why?
Neurosurgical Procedures
1
2011
126
0.020
Why?
Gene Expression Regulation, Leukemic
1
2009
29
0.020
Why?
Comorbidity
1
2011
621
0.020
Why?
Up-Regulation
1
2009
446
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2013
997
0.020
Why?
Transcription, Genetic
1
2008
354
0.020
Why?
Liver
1
2013
1126
0.020
Why?
Follow-Up Studies
1
2011
2231
0.020
Why?
Tomography, X-Ray Computed
1
2011
1163
0.020
Why?
Postoperative Complications
1
2011
1030
0.010
Why?
Child
1
2011
6931
0.010
Why?
Laudadio's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_